Jubilant inks deal to invest $25M in Sofie

By AuntMinnie.com staff writers

November 4, 2020 -- Jubilant Radiopharma will invest $25 million into molecular imaging developer Sofie Biosciences under a new partnership agreement.

Jubilant will have a 25% equity holding in Sofie, with the investment helping Sofie expand production capacity, advance theranostics, and support new PET diagnostic manufacturing and distribution within the U.S. Funds will be used to speed up the readiness timelines of Sofie's theranostics manufacturing facility in Totowa, NJ, and to further develop its fibroblast activation protein inhibitor (FAPI) program.

FAPI is being developed as a theranostic agent to improve the detection and treatment of a wide variety of oncology diseases, according to the company.


Copyright © 2020 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: